Advertisement for orthosearch.org.uk
Results 1 - 3 of 3
Results per page:
Bone & Joint Open
Vol. 5, Issue 12 | Pages 1101 - 1107
11 Dec 2024
Haas-Lützenberger EM Emelianova I Bader MC Mert S Moellhoff N Demmer W Berger U Giunta R

Aims

In the treatment of basal thumb osteoarthritis (OA), intra-articular autologous fat transplantation has become of great interest within recent years as a minimally invasive and effective alternative to surgical intervention with regard to pain reduction. This study aims to assess its long-term effectiveness.

Methods

Patients diagnosed with stage one to three OA received a single intra-articular autologous fat transplantation. Fat tissue was harvested from the abdomen and injected into the trapeziometacarpal (TMC) joint under radiological guidance, followed by one week of immobilization. Patients with a minimum three-year post-procedure period were assessed for pain level (numerical rating scale), quality of life (Mental Health Quotient (MHQ)), the abbreviated version of the Disabilities of Arm, Shoulder and Hand questionnaire (QuickDASH)), and grip and pinch strength, as well as their overall impression of the treatment. Wilcoxon tests compared data from pre-intervention, and at one and three years post-intervention.


Bone & Joint 360
Vol. 9, Issue 5 | Pages 28 - 32
1 Oct 2020


Orthopaedic Proceedings
Vol. 91-B, Issue SUPP_I | Pages 96 - 96
1 Mar 2009
APARD T CAST YS
Full Access

Introduction: The surgical gold standart treatment of the thumb osteoarthritis is the trapeziectomy with tendon interposition and ligament reconstruction. The trapeziometacarpal prosthesis is an option badly estimated in the literature.

Between 1994 and 2001, 43 non-cimented trapeziometacarpal prosthesis ARPE® (Biomet) was implanted by the same operator for isolated trapezio-metacarpal degenerative osteoarthritis. The minimal follow-up is 5 years.

The aim of this study is to evaluate the fonction of the thumb with a 5 year-old or more trapeziometacarpal prosthesis. The technique is described and the revisions are analysed.

Material and methods: 33 women and 2 men, mean age 59,4-years, were operated after failure of the conservative treatment. There are 7 lost sight (9 prosthesis) and 2 deaths (2 prosthesis). 27 other patients (32 prostheses) were examined by the author with an original revision questionnary associated to the score of DASH. The average follow up for the 25 prosthesis always implanted is 86 months.

7 revisions (16%) were necessary on average after 34 months (1 month in 10 years) : 5 for loosenning, 1 for premature dismantling and 1 for recurrent partial dislocation. 6 were treated by trapeziectomy with tendinous interposition of palmaris longus according to the technique of F.E. Jones.

Results: The mobility is perfect for all patients but one. There is no tendancy for the cup or steem to sink into the bone but there is often some medial calcifications around the trapezium. Average DASH score is 27.4/100. There is no infection and only one dislocation at 1 months (reduction by closed procedure). The survival of the prosthesis is 85% in 5 years.

In the first 13 months, 4 revisions is necessary. The ablation of the cup is easy but the extraction of de metacarpal still is often difficult. The scaphometacarpal height is constantly lowered (34,5 % on average). Aesthetically, 2 patients are disappointed and preferred their thumb with prosthesis.

Discussion and conclusion: The prosthesis ARPE ® is an effective option in this series for the treatment of the degenerative trapeziometacarpal osteoarthritis but its radioclinic control is necessary for the first year.